Kuanliang International Investment Forum Kicks Off in Singapore on April 14th; Record High 43 Taiwanese Companies Participate

Kuanliang International founder and CEO Li Hongji announced via press release that this forum is a collaborative effort between Kuanliang International, the Biomedical and Medical Device Research Laboratories of the Industrial Technology Research Institute (ITRI), and AAMA Taipei (Taipei Cradle Program), themed "AI, Biotech, and Beyond."

Li Hongji pointed out that the international institutional investors participating in the forum collectively manage over US$20 trillion (approximately NT$635 trillion) in assets. He emphasized that this is not just an investment forum, but also the best platform for Taiwanese companies with "hidden champion" potential to showcase their technological moats, optimize their shareholder structures, and connect with international investment institutions.

Over the past 14 years, Kuanliang International has successfully held 18 editions of its CEO Week, facilitating in-depth exchanges between more than 200 Taiwanese companies and over 30,000 international professional investors.

The 43 Taiwanese companies participating in the 19th QIC CEO Week span core sectors such as new economy, biomedical and healthcare, semiconductors, renewable energy, artificial intelligence (AI), cloud services, financial services, and consumer industries. Notable participating companies include Zentronic-KY, Win Semiconductors, Chang Sheng, and Medigen Vaccine Biologics. (Editor: Chang Ruo-yao) 1150413